Spruce Biosciences/$SPRB
1D1W1MYTD1Y5YMAX
Capital at risk
About Spruce Biosciences
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.
- Ticker
- $SPRB
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 22
- Headquarters
- South San Francisco, United States
- Website
- sprucebio.com
SPRB Metrics
BasicAdvanced
$155M
-
-$36.05
3.34
-
Price and volume
Market cap
$155M
Beta
3.34
52-week high
$240.00
52-week low
$7.26
Average daily volume
84K
Financial strength
Current ratio
9.227
Quick ratio
8.784
Long term debt to equity
0.058
Total debt to equity
0.092
Interest coverage (TTM)
-22.23%
Profitability
EBITDA (TTM)
-39.037
Management effectiveness
Return on assets (TTM)
-40.03%
Return on equity (TTM)
-105.98%
Valuation
Price to book
1.77
Price to tangible book (TTM)
1.77
Price to free cash flow (TTM)
-1.794
Free cash flow yield (TTM)
-55.74%
Free cash flow per share (TTM)
-30.023
Growth
Earnings per share change (TTM)
-57.47%
3-year earnings per share growth (CAGR)
-33.17%
Upcoming events
No upcoming events
SPRB News
AllArticlesVideos
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Wire1 week ago
Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Business Wire2 months ago
Spruce Biosciences Joins the Russell 3000® Index
Business Wire3 months ago
Funds containing SPRB
Fund name | Fund size | $SPRB weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.